Literature DB >> 3003486

Cross-tolerance studies between caffeine and (-)-N6-(phenylisopropyl)-adenosine (PIA) in mice.

M K Ahlijanian, A E Takemori.   

Abstract

Chronic administration of caffeine to mice (1 mg/ml in drinking water X 14 d) led to a downward shift in the dose-response curve for the locomotor effects of caffeine. Caffeine was also less effective as an antagonist against (-)-(N6-phenylisopropyl)-adenosine (PIA)-induced analgesia in the tail flick assay in these animals. The dose-response curves of PIA for both analgesia and locomotor depression were shifted to the left in animals chronically administered caffeine. In mice chronically administered PIA (1 mg/kg/d X 14 d), the dose-response curves of PIA for both analgesia and locomotor depression were shifted to the right. The dose-response curve for the locomotor effects of caffeine was shifted to the left, and caffeine exhibited greater antagonist activity against the analgesic action of PIA in these animals. There was no change in the Kd or Bmax values of either 3H-PIA or 3H-diethylphenylxanthine (DPX, a potent adenosine receptor antagonist) in mice chronically administered PIA. The Bmax values for both 3H-PIA and 3H-DPX were significantly increased, while the Kd values were not changed in mice chronically administered caffeine. There was no detectable change in the brain levels of either PIA or caffeine in animals chronically treated with either drug. The results demonstrate that chronic administration of caffeine increases the sensitivity of mice to the actions of PIA and vice versa, providing supportive evidence for the interaction of these drugs at the same receptor, which is probably an adenosine receptor.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3003486     DOI: 10.1016/0024-3205(86)90051-2

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  9 in total

1.  The role of adenosine receptors in the central action of caffeine.

Authors:  John W Daly; Dan Shi; Olga Nikodijevic; Kenneth A Jacobson
Journal:  Pharmacopsychoecologia       Date:  1994

Review 2.  Pharmacological rationale for the clinical use of caffeine.

Authors:  J Sawynok
Journal:  Drugs       Date:  1995-01       Impact factor: 9.546

Review 3.  Caffeine physical dependence: a review of human and laboratory animal studies.

Authors:  R R Griffiths; P P Woodson
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

4.  Chronic caffeine alters the density of adenosine, adrenergic, cholinergic, GABA, and serotonin receptors and calcium channels in mouse brain.

Authors:  D Shi; O Nikodijević; K A Jacobson; J W Daly
Journal:  Cell Mol Neurobiol       Date:  1993-06       Impact factor: 5.046

5.  Effect of long term caffeine treatment on A1 and A2 adenosine receptor binding and on mRNA levels in rat brain.

Authors:  B Johansson; S Ahlberg; I van der Ploeg; S Brené; N Lindefors; H Persson; B B Fredholm
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-04       Impact factor: 3.000

6.  Multiple components of the A1 adenosine receptor-adenylate cyclase system are regulated in rat cerebral cortex by chronic caffeine ingestion.

Authors:  V Ramkumar; J R Bumgarner; K A Jacobson; G L Stiles
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

7.  Pharmacologic specificity of tolerance to caffeine-induced stimulation of locomotor activity.

Authors:  I B Finn; S G Holtzman
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

8.  Locomotor activity in mice during chronic treatment with caffeine and withdrawal.

Authors:  O Nikodijević; K A Jacobson; J W Daly
Journal:  Pharmacol Biochem Behav       Date:  1993-01       Impact factor: 3.533

Review 9.  Adenosine receptor ligands: differences with acute versus chronic treatment.

Authors:  K A Jacobson; D K von Lubitz; J W Daly; B B Fredholm
Journal:  Trends Pharmacol Sci       Date:  1996-03       Impact factor: 14.819

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.